Literature DB >> 20851104

ADAM15 expression is downregulated in melanoma metastasis compared to primary melanoma.

Christopher Ungerer1, Kai Doberstein, Claudia Bürger, Katja Hardt, Wolf-Henning Boehncke, Beate Böhm, Josef Pfeilschifter, Reinhard Dummer, Daniela Mihic-Probst, Paul Gutwein.   

Abstract

In a mouse melanoma metastasis model it has been recently shown that ADAM15 overexpression in melanoma cells significantly reduced the number of metastatic nodules on the lung. Unfortunately, the expression of ADAM15 in human melanoma tissue has not been determined so far. In our study, we characterized the expression of ADAM15 in tissue micro-arrays of patients with primary melanoma with melanoma metastasis. ADAM15 was expressed in melanocytes and endothelial cells of benign nevi and melanoma tissue. Importantly, ADAM15 was significantly downregulated in melanoma metastasis compared to primary melanoma. We further demonstrate that IFN-γ and TGF-β downregulate ADAM15 protein levels in melanoma cells. To investigate the role of ADAM15 in melanoma progression, we overexpressed ADAM15 in melanoma cells. Importantly, overexpression of ADAM15 in melanoma cells reduced the migration, invasion and the anchorage dependent and independent cell growth of melanoma cells. In summary, the downregulation of ADAM15 plays an important role in melanoma progression and ADAM15 act as a tumorsuppressor in melanoma.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20851104     DOI: 10.1016/j.bbrc.2010.09.055

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  The nine ADAMs family members serve as potential biomarkers for immune infiltration in pancreatic adenocarcinoma.

Authors:  Bing Qi; Han Liu; Ying Dong; Xueying Shi; Qi Zhou; Fen Zeng; Nabuqi Bao; Qian Li; Yuan Yuan; Lei Yao; Shilin Xia
Journal:  PeerJ       Date:  2020-09-30       Impact factor: 2.984

2.  Molecular genetic study of novel biomarkers for early diagnosis of oral squamous cell carcinoma.

Authors:  Kim Yong-Deok; Jeon Eun-Hyoung; Kim Yeon-Sun; Pang Kang-Mi; Lee Jin-Yong; Cho Sung-Hwan; Kim Tae-Yun; Park Tae-Sung; Kim Soung-Min; Kim Myung-Jin; Lee Jong-Ho
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-03-01

3.  Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers.

Authors:  Christoph Burdelski; Michael Fitzner; Claudia Hube-Magg; Martina Kluth; Asmus Heumann; Ronald Simon; Till Krech; Till Clauditz; Franziska Büscheck; Stefan Steurer; Corinna Wittmer; Andrea Hinsch; Andreas M Luebke; Frank Jacobsen; Sarah Minner; Maria Christina Tsourlakis; Burkhard Beyer; Thomas Steuber; Imke Thederan; Guido Sauter; Jakob Izbicki; Thorsten Schlomm; Waldemar Wilczak
Journal:  Neoplasia       Date:  2017-03-08       Impact factor: 5.715

4.  Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy.

Authors:  Chunai Gong; Jing Tian; Zhuo Wang; Yuan Gao; Xin Wu; Xueying Ding; Lei Qiang; Guorui Li; Zhimin Han; Yongfang Yuan; Shen Gao
Journal:  J Nanobiotechnology       Date:  2019-09-03       Impact factor: 10.435

5.  NCK1-AS1 promotes the progression of melanoma by accelerating cell proliferation and migration via targeting miR-526b-5p/ADAM15 axis.

Authors:  Quan Lin; Yan Jia; Duo Zhang; Hongjuan Jin
Journal:  Cancer Cell Int       Date:  2021-07-12       Impact factor: 5.722

6.  Insights into the Transforming Growth Factor-β Signaling Pathway in Cutaneous Melanoma.

Authors:  Carole Yolande Perrot; Delphine Javelaud; Alain Mauviel
Journal:  Ann Dermatol       Date:  2013-05       Impact factor: 1.444

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.